Related Experiment Video
Updated: Apr 10, 2026

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
Published on: February 23, 2015
Hormone-dependence of sarin lethality in rats: Sex differences and stage of the estrous cycle
Carl D Smith1, Linnzi K M Wright1, Gregory E Garcia1
1US Army Medical Research Institute of Chemical Defense (USAMRICD), Aberdeen Proving Ground, MD 21010, United States.
Abstract:
Chemical warfare nerve agents (CWNAs) are highly toxic compounds that cause a cascade of symptoms and death, if exposed casualties are left untreated. Numerous rodent models have investigated the toxicity and mechanisms of toxicity of CWNAs, but most are limited to male subjects. Given the profound physiological effects of circulating gonadal hormones in female rodents, it is possible that the daily cyclical fluctuations of these hormones affect females' sensitivity to the lethal effects of CWNAs, and previous reports that included female subjects did not control for the stage of the hormonal cycle. The aim of the current study was to determine the 24-hour median lethal dose (LD50) of the CWNA sarin in male, ovariectomized (OVEX) female, and female rats during different stages of the estrous cycle (diestrus, proestrus, and estrus). Additionally, baseline activity levels of plasma acetylcholinesterase, butyrylcholinesterase, and carboxylesterase were measured to determine differences among the groups. Results indicated that females in proestrus had a significantly higher LD50 of sarin compared to OVEX and estrous females. Although some sex differences were observed in the activity levels of plasma esterases, they were not consistent and likely not large enough to significantly affect the LD50s. These results suggest that hormonal cyclicity can influence the outcome of CWNA-related studies using female rodents, and that this variability can be minimized by controlling for the stage of the cycle. Additional research is necessary to determine the precise mechanism of the observed differences because it is unlikely to be solely explained by plasma esterase activity.
Insights
Female rats' sensitivity to lethal chemical warfare nerve agents (CWNAs) like sarin varies with their hormonal cycle. Proestrus females showed higher sarin LD50, suggesting cycle stage impacts toxicity studies.
Area of Science:
- Toxicology
- Neuroscience
- Endocrinology
Background:
- Chemical warfare nerve agents (CWNAs) pose significant health risks, with rodent models crucial for research.
- Most CWNA toxicity studies exclude females or fail to account for hormonal cycle variations.
- Gonadal hormones in females may influence sensitivity to CWNA lethality.
Purpose of the Study:
- To determine the median lethal dose (LD50) of sarin in male, ovariectomized (OVEX) female, and cycling female rats.
- To assess baseline plasma esterase activity across different groups.
- To investigate the impact of the estrous cycle on sarin toxicity.
Main Methods:
- Determined 24-hour LD50 of sarin in male, OVEX female, and female rats at diestrus, proestrus, and estrus.
- Measured plasma acetylcholinesterase, butyrylcholinesterase, and carboxylesterase activity.
- Compared LD50 values and esterase activity across experimental groups.
Main Results:
- Females in proestrus exhibited a significantly higher sarin LD50 compared to OVEX and estrous females.
- Observed sex differences in plasma esterase activity were inconsistent and unlikely to significantly impact LD50.
- Hormonal cyclicity in female rodents influences sarin toxicity outcomes.
Conclusions:
- Female rodent sensitivity to sarin is modulated by the estrous cycle stage.
- Controlling for the hormonal cycle is essential for minimizing variability in CWNA toxicity studies.
- Further research is needed to elucidate the mechanisms underlying these hormonal influences on CWNA toxicity, beyond plasma esterase activity.
Related Concept Videos
Toxicity Testing in Animals
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...

